Probiotics: Contributions to oral health

Oral Diseases

Volumn 13, Issue 5, 2007, Pages 443-451

  Meurman, J H ^a   Stamatova, I ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Bifidobacteria; Candida; Lactobacilli; Oral health; Probiotics; W. cibaria

Indexed keywords

PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; CANCER RISK; CLINICAL RESEARCH; DENTAL CARE; DENTAL CARIES; DENTAL HEALTH; DRUG MECHANISM; HALITOSIS; HUMAN; IMMUNE RESPONSE; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; THERAPY EFFECT; TREATMENT RESPONSE; WALDEYER RING;

DENTAL CARIES; HUMANS; MOUTH; PERIODONTAL DISEASES; PROBIOTICS; STREPTOCOCCUS MUTANS;

EID: 34547838929     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01386.x     Document Type: Review

References (67)

1. Ahola AJ, Yli-Knuuttila H, Suomalainen T et al (2002). Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol 47 : 799 804.
2. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y (2005). Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 24 : 257 265.
3. Anderson MH, Shi W (2006). A probiotic approach to caries management. Pediatr Dent 28 : 151 153.
4. Banchereau J, Steinman RM (1998). Dendritic cells and the control of immunity. Nature 392 : 245 252.
5. Bergonzelli GE, Blum S, Brussow H, Corthesy-Theulaz I (2005). Probiotics as a treatment strategy for gastrointestinal diseases? Digestion 72 : 57 68.
6. Boriello SP, Hammes WP, Holzapfel W et al (2003). Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36 : 775 780.
7. Boris S, Suarez JE, Barbes C (1997). Characterization of the aggregation promoting factor from Lacobacillus gasseri, a vaginal isolate. J Appl Microbiol 83 : 413 420.
8. Brzozowski T, Konturek PC, Mierzwa M et al (2006). Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils. Helicobacter 11 : 10 20.
9. Burton JO, Chilcott CN, Tagg JR (2005). The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis 11 (Suppl. I 29 31.
10. Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR (2006a). Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72 : 3050 3053.
11. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR (2006b). A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100 : 754 764.
12. Busscher HJ, Mulder AF, van der Mei CH (1999). In vitro adhesion to enamel and in vivo colonization of tooth surfaces by lactobacilli from a bio-yogurt. Caries Res 33 : 403 404.
13. Çaglar E, Kargul B, Tanboga I (2005a). Bacteriotherapy and probiotics' role on oral health. Oral Dis 11 : 131 137.
14. Çaglar E, Sandalli N, Twetman S, Kavaloglu S, Ergeneli S, Selvi S (2005b). Effect of yogurt with Bifidobacterium DN-173 010 on salivary mutans streptococci and lactobacilli in young adults. Acta Odontol Scand 63 : 317 320.
15. Çaglar E, Cilder SK, Ergeneli S, Sandalli N, Twetman S (2006). Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55739 by straws or tablets. Acta Odontol Scand 64 : 314 318.
16. Cannon JP, Lee TA, Bolanos JT, Danzinger LH (2005). Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24 : 31 40.
17. Christensen HR, Larsen CN, Kaestel P et al (2006). Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults. FEMS Immunol Med Microbiol 47 : 380 390.
18. Colloca ME, Ahumada MC, Lopez ME, Nader-Macias ME (2000). Surface properties of lactobacilli isolated from healthy subjects. Oral Dis 6 : 227 233.
19. Commane D, Hughes R, Shortt C, Rowland I (2005). The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res 11 : 276 289.
20. Elahi S, Pang G, Clancy A, Clancy R (2005). Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus. Clin Exp Immunol 141 : 29 36.
21. El-Nezami HS, Polychronaki NN, Ma J et al (2006). Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr 83 : 1199 1203.
22. Falagas ME, Betsi GI, Tokas T, Athanasiou S (2006). Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 66 : 1253 1261.
23. Grajek W, Olejnik A, Sip A (2005). Probiotics, prebiotics and antioxidants as functional foods. Acta Biochim Pol 52 : 665 671.
24. Grangette C, Müller-Alouf H, Goudercourt D, Geoffroy M-C, Turneer M, Mereenier A (2001). Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant L. plantarum. Infect Immun 69 : 1547 1553.
25. Guarner F, Perdigon G, Coerthier G, Salminen S, Koletzko B, Morelli L (2005). Should yoghurt cultures be considered probiotic? Br J Nutr 93 : 783 786.
26. Hart AL, Lammers K, Brigidi P et al (2004). Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53 : 1602 1609.
27. Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JK (2007). Probiotics reduce the prevalence of oral Candida in the elderly - a randomized controlled trial. J Dent Res 86 : 125 130.
28. Haukioja A, Yli-Knuuttila H, Liomaranta V et al (2006a). Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Micorbiol Immunol 21 : 326 332.
29. Haukioja A, Loimarant V, Tenovuo J (2006b). Effect of lactobacilli and bifidobacterium on streptococcal adherence. IADR Congress, Dublin, 13 16 September (Abstract 0702).
30. Husni RN, Gordon SM, Washington JA, Longworth DL (1997). Lactobacillus bacteremia and endocarditis review of 45 cases. Clin Infect Dis 25 : 1048 1055.
31. Hutt P, Shchepetova J, Loivukene K, Kullisaar T, Mikelsaar M (2006). Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol 100 : 1324 1332.
32. Huys G, D'Haene K, Swings J (2006). Genetic basis of tetracycline and minocycline resistance in potentially probiotic Lactobacillus plantarum strain CCUG 43738. Antimicrob Agents Chemother 50 : 1550 1551.
33. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S (2001). Probiotics: effects on immunity. Am J Clin Nutr 73 (Suppl. 2 S444 S450.
34. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R (2005). Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 18 : 1600 1605.
35. Kang MS, Na HS, Oh LS (2005). Coaggregation ability of Weissella cibaria isolates with Fusobacterium nucleatum and their adhesiveness to epithelial cells. FEMS Microbiol Lett 253 : 323 329.
36. Kang M-S, Kim B-G, Lee H-C, Oh J-S (2006). Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol 33 : 226 232.
37. Kazor CE, Mitchell PM, Lee AM et al (2003). Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol 41 : 558 563.
38. Kolenbrander PE (2000). Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 54 : 413 437.
39. Kõll-Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M (2005). Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 20 : 354 361.
40. Kõll-Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M (2006). Oral lactobacilli in chronic periodontitis: species composition and antimicrobial activity. IADR Congress, Dublin, 13 16 September (Abstract 0081).
41. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G (2006). Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 30 : 55 60.
42. Lester CH, Frimodt-Moller N, Sorensen TL, Monnet DL, Hammerun AM (2006). In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother 50 : 596 599.
43. Lewis SJ, Freedman AR (1998). The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 12 : 807 822.
44. Lima LM, Motisuki C, Spolidorio DM, Santos-Pintol L (2005). In vitro evaluation of probiotics microorganisms adhesion to an artificial caries model. Eur J Clin Nutr 59 : 884 886.
45. Marsh P, Martin MV (1999). Oral Microbiology. 4th edn. Wright : Oxford.
46. Masco L, Van Hoorde K, De Brandt E, Swings J, Huys G (2006). Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. J Antimicrob Chemother 58 : 85 94.
47. Mego M, Majek J, Koncekova R et al (2005). Intramucosal bacteria in colon cancer and their elimination by probiotic strain Enterococcus faecium M-74 with organic selenium. Folia Microbiol (Praha) 50 : 443 7.
48. Meurman JH (2005). Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 113 : 188 196.
49. Meurman JH, Antila H, Salminen S (1994). Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium. Microb Ecol Health Dis 7 : 295 298.
50. Montalto M, Vastola M, Marigo L et al (2004). Probiotics treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study. Digestion 69 : 53 56.
51. Näse L, Hatakka K, Savilahti E et al (2001). Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk children. Caries Res 35 : 412 420.
52. Nikawa H, Makihira S, Fukushima H, Nishimura H, Ozaki Y, Ishida K (2004). Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol 95 : 219 223.
53. Olivares M, Diaz-Ropero MP, Martin R, Rodriguez JM, Xaus J (2006). Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol 101 : 72 79.
54. Oliveira ML, Areas AP, Campos IB et al (2006). Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 8 : 1016 1024.
55. Ostengo MC, Nader-Macias EM (2004). Hydroxylapatite beads as an experimental model to study adhesion of lactic acid bacteria from the oral cavity to hard tissues. Methods Mol Biol 268 : 447 452.
56. Paster BJ, Boches SK, Galvin JL et al (2001). Bacterial diversity in human subgingival plaque. J Bacteriol 183 : 3770 3783.
57. Reid G, McGroarty JA, Angotti R, Cook RL (1988). Lactobacillus inhibitor production against Escherichia coli and coaggregation ability with uropathogens. Can J Microbiol 34 : 344 351.
58. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001). Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 30 : 49 52.
59. Rinne M, Kalliomaki M, Arvilommi H, Salminen S, Isolauri E (2005). Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/ enterococcus microbiota and humoral immune responses. J Pediatr 147 : 186 191.
60. Salminen M (2006). Lactobacillus bacteremia, with special focus on the safety of probiotic Lactobacillus rhamnosus GG. Dissertation Thesis, University of Helsinki : Helsinki.
61. Salminen MK, Tynkkynen S, Hilpi R et al (2002). Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35 : 1155 1156.
62. Silva M, Jacobus NV, Deneke C, Gorbach SL (1987). Antimicrobial substance from a human lactobacillus strain. Antimicrob Agents Chemother 31 : 1231 1233.
63. Teanpaisan R, Dahlen G (2006). Use of polymerase chain reaction techniques and sodium dodecyl sulphate-polyacrylamide get electrophoresis for differentiation of oral Lactobacillus species. Oral Microbiol Immunol 21 : 79 83.
64. Volozhin AI, Il'in VK, Maksimovskii IM et al (2004). Development and use of periodontal dressing of collagen and Lactobacillus casei 37 cell suspension in combined treatment of periodontal disease of inflammatory origin (a microbiological study). Stomatologiia (Mosk) 83 : 6 8.
65. Wolf BW, Wheeler D, Ataya DG, Garleb KA (1998). Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol 36 : 1085 1094.
66. Wu H-Y, Nguyen HH, Russell MW (1997). Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 46 : 506 513.
67. Yli-Knuuttila H, Snäll J, Kari K, Meurman JH (2006). Colonization of Lactobacillus rhamnosus GG in the oral cavity. Oral Microbiol Immunol 21 : 129 131.